KXV01 TCR lentinvivo
/ TCRx Therap
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
December 30, 2025
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
(clinicaltrials.gov)
- P1/2 | N=600 | Not yet recruiting | Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
IO biomarker • New P1/2 trial • Oncology • Solid Tumor
December 11, 2025
Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: TCRx Therapeutics Co.Ltd
New P1 trial • Solid Tumor
October 07, 2025
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: The First Hospital of Jilin University
New P1 trial • Solid Tumor
September 29, 2025
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: TCRx Therapeutics Co.Ltd
New P1 trial • Oncology • Solid Tumor
1 to 4
Of
4
Go to page
1